CAPTRUST Financial Advisors
VNDA icon

CAPTRUST Financial Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
36,376
+20,739
+133% +$135K ﹤0.01% 2806
2026
Q1 		$108K Buy
+15,637
New +$121K ﹤0.01% 2803
2024
Q1 		– Sell
-13,943
Closed -$58.8K – 2664
2023
Q4 		$58.8K Buy
+13,943
New +$56.3K ﹤0.01% 2574
2022
Q3 		– Sell
-1,130
Closed -$12K – 4014
2022
Q2 		$12K Sell
1,130
-537
-32% -$5.56K ﹤0.01% 3667
2022
Q1 		$19K Sell
1,667
-173
-9% -$2.27K ﹤0.01% 3429
2021
Q4 		$29K Buy
1,840
+224
+14% +$3.9K ﹤0.01% 3051
2021
Q3 		$28K Buy
1,616
+16
+1% +$280 ﹤0.01% 2950
2021
Q2 		$34K Hold
1,600
– – ﹤0.01% 2759
2021
Q1 		$24K Buy
1,600
+1,495
+1,424% +$24.2K ﹤0.01% 2898
2020
Q4 		$1K Buy
105
+55
+110% +$662 ﹤0.01% 3322
2020
Q3 		$0 Buy
+50
New +$534 ﹤0.01% 3251

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAPTRUST Financial Advisors's VNDA Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Vanda Pharmaceuticals (VNDA) stake by 133% in Q2 2026, buying an estimated $135K and bringing the position to 36,376 shares worth $223K. The position accounts for ﹤0.01% of the portfolio, ranked #2806.

CAPTRUST Financial Advisors first reported a position in VNDA in Q3 2020 and has held it in 11 quarters since. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • CAPTRUST Financial Advisors held 36,376 shares of Vanda Pharmaceuticals worth $223K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 20,739 Vanda Pharmaceuticals shares in Q2 2026, an estimated $135K.
  • Vanda Pharmaceuticals made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2806 holding.
  • CAPTRUST Financial Advisors first reported a position in Vanda Pharmaceuticals in Q3 2020 and has held it in 11 quarters since.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.